The Scientist

» reagents and cell & molecular biology

Most Recent

image: Scorpion Venom Kills MRSA

Scorpion Venom Kills MRSA

By | July 12, 2012

Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.

2 Comments

Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.

0 Comments

image: Ubiquitin Chains in Action

Ubiquitin Chains in Action

By | July 1, 2012

Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.

0 Comments

image: 3-D Printing

3-D Printing

By | July 1, 2012

Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.

2 Comments

image: Dynamic Delivery

Dynamic Delivery

By | July 1, 2012

Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.

0 Comments

image: Move Over, Mother Nature

Move Over, Mother Nature

By | July 1, 2012

Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.

5 Comments

image: Munching Macrophages

Munching Macrophages

By | July 1, 2012

Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.

1 Comment

image: On the Chain Gang

On the Chain Gang

By | July 1, 2012

Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.

1 Comment

image: Sweet Smell of Success

Sweet Smell of Success

By | July 1, 2012

Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.

2 Comments

image: The Little Cell That Could

The Little Cell That Could

By | July 1, 2012

Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech